Found: 19
Select item for more details and to access through your institution.
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 12, p. 1, doi. 10.1038/s41419-018-1185-6
- By:
- Publication type:
- Article
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.668573
- By:
- Publication type:
- Article
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6665, doi. 10.3390/ijms22136665
- By:
- Publication type:
- Article
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 11, p. 2382, doi. 10.3390/ijms18112382
- By:
- Publication type:
- Article
NOTCH and Graft-Versus-Host Disease.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01825
- By:
- Publication type:
- Article
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL Correspondence.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 4, p. 404, doi. 10.1111/j.1365-2141.2010.08368.x
- By:
- Publication type:
- Article
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1218989
- By:
- Publication type:
- Article
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 1, p. 182, doi. 10.1002/eji.201242643
- By:
- Publication type:
- Article
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 416, doi. 10.1111/bjh.19052
- By:
- Publication type:
- Article
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.
- Published in:
- 2017
- By:
- Publication type:
- journal article
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion.
- Published in:
- 2013
- By:
- Publication type:
- journal article
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion.
- Published in:
- International Journal of Hematology, 2013, v. 98, n. 2, p. 153, doi. 10.1007/s12185-013-1368-y
- By:
- Publication type:
- Article
Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1272798
- By:
- Publication type:
- Article
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3618, doi. 10.3390/cancers15143618
- By:
- Publication type:
- Article
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00229
- By:
- Publication type:
- Article
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00105
- By:
- Publication type:
- Article
Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 4, p. 958, doi. 10.1002/ijc.31355
- By:
- Publication type:
- Article